scholarly journals Unprecedented deoxygenation at C-7 of the ansamitocin core during mutasynthetic biotransformations

2012 ◽  
Vol 8 ◽  
pp. 861-869 ◽  
Author(s):  
Tobias Knobloch ◽  
Gerald Dräger ◽  
Wera Collisi ◽  
Florenz Sasse ◽  
Andreas Kirschning

We describe the unprecedented formation of six ansamitocin derivatives that are deoxygenated at C-7 of the ansamitocin core, obtained during fermentation experiments by employing a variety of Actinosynnema pretiosum mutants and mutasynthetic approaches. We suggest that the formation of these derivatives is based on elimination at C-7/C-8 followed by reduction(s) of the intermediate enone. In bioactivity tests, only ansamitocin derivatives bearing an ester side chain at C-3 showed strong antiproliferative activity.

2014 ◽  
Vol 10 ◽  
pp. 535-543 ◽  
Author(s):  
Kirsten Harmrolfs ◽  
Lena Mancuso ◽  
Binia Drung ◽  
Florenz Sasse ◽  
Andreas Kirschning

The preparation of alkyne-modified ansamitocins by mutasynthetic supplementation of Actinosynnema pretiosum mutants with alkyne-substituted aminobenzoic acids is described. This modification paved the way to introduce a thiol linker by Huisgen-type cycloaddition which can principally be utilized to create tumor targeting conjugates. In bioactivity tests, only those new ansamitocin derivatives showed strong antiproliferative activity that bear an ester side chain at C-3.


2017 ◽  
Vol 13 (4) ◽  
pp. 375-383 ◽  
Author(s):  
Chunfang Gan ◽  
Liang Liu ◽  
Jianguo Cui ◽  
Zhiping Liu ◽  
Haixin Shi ◽  
...  

2019 ◽  
Vol 20 (5) ◽  
pp. 1113 ◽  
Author(s):  
Fabienne Gaugaz ◽  
Andrea Chicca ◽  
Mariano Redondo-Horcajo ◽  
Isabel Barasoain ◽  
J. Díaz ◽  
...  

A new simplified, epoxide-free epothilone analog was prepared incorporating an N-(2-hydroxyethyl)-benzimidazole side chain, which binds to microtubules with high affinity and inhibits cancer cell growth in vitro with nM potency. Building on this scaffold, a disulfide-linked conjugate with the purported EGFR-binding (EGFR, epidermal growth factor receptor) peptide GE11 was then prepared. The conjugate retained significant microtubule-binding affinity, in spite of the size of the peptide attached to the benzimidazole side chain. The antiproliferative activity of the conjugate was significantly lower than for the parent scaffold and, surprisingly, was independent of the EGFR expression status of cells. Our data indicate that the disulfide-based conjugation with the GE11 peptide is not a viable approach for effective tumor-targeting of highly potent epothilones and probably not for other cytotoxics.


Steroids ◽  
2002 ◽  
Vol 67 (9) ◽  
pp. 789-798 ◽  
Author(s):  
Michał Chodyński ◽  
Joanna Wietrzyk ◽  
Ewa Marcinkowska ◽  
Adam Opolski ◽  
Wiesław Szelejewski ◽  
...  

Molecules ◽  
2021 ◽  
Vol 26 (3) ◽  
pp. 557
Author(s):  
Andrea Spallarossa ◽  
Matteo Lusardi ◽  
Chiara Caneva ◽  
Aldo Profumo ◽  
Camillo Rosano ◽  
...  

Pyrimido-pyrimidine derivatives have been developed as rigid merbarone analogues. In a previous study, these compounds showed potent antiproliferative activity and efficiently inhibited topoisomerase IIα. To further extend the structure–activity relationships on pyrimido-pyrimidines, a novel series of analogues was synthesized by a two-step procedure. Analogues 3–6 bear small alky groups at positions 1 and 3 of the pyrimido-pyrimidine scaffold whereas at position 6a (4-chloro)phenyl substituent was inserted. The basic side chains introduced at position 7 were selected on the basis of the previously developed structure–activity relationships. The antiproliferative activity of the novel compounds proved to be affected by both the nature of the basic side chain and the substituents on the pyrimido-pyrimidine moiety. Derivatives 5d and 5e were identified as the most promising molecules still showing reduced antiproliferative activity in comparison with the previously prepared pyrimido-pyrimidine analogues. In topoisomerase IIα-5d docking complex, the ligand would poorly interact with the enzyme and assume a different orientation in comparison with 1d bioactive conformation.


2013 ◽  
Vol 1049 ◽  
pp. 355-361 ◽  
Author(s):  
Sanjima Pal ◽  
Mahesh Jadhav ◽  
Thomas Weyhermüller ◽  
Yogesh Patil ◽  
M. Nethaji ◽  
...  

2016 ◽  
Vol 11 (2) ◽  
pp. 1934578X1601100
Author(s):  
Naoki Kokudo ◽  
Mina Okazoe ◽  
Joji Takahashi ◽  
Kanako Iseki ◽  
Kazuko Yoshikawa ◽  
...  

During the search for secondary metabolites with antiproliferative activity, six new lanostane triterpenoids, tyrosamic acids A-F (1–6) together with ten known compounds (7–16), were isolated from the fruiting body of Tyromyces sambuceus. Their structures were elucidated using MS analyses, extensive 2D-heteronuclear NMR data interpretation and the structure of 3 was further confirmed by single-crystal X-ray data analyses. All lanostane triterpenoids (1–16) possesses a carboxy group at C-20 position and their strength of antiproliferative activity was affected by the presence or absence of a hydroxy group at C-15 position and at the side chain. Four of the compounds (1, 6, 10, 14) showed antiproliferative activities against human cancer cell lines with IC50 values of 16.8–48.3 μM (HL-60).


2019 ◽  
Vol 84 (12) ◽  
pp. 1345-1353
Author(s):  
Bojana Sreco-Zelenovic ◽  
Sladjana Kekezovic ◽  
Mirjana Popsavin ◽  
Vesna Kojic ◽  
Goran Benedekovic ◽  
...  

Divergent syntheses of novel (?)-goniofufurone mimics with an alkoxymethyl group as the side chain have been accomplished from D-glucose in nine synthetic steps and in overall yields 6.7?8.7 %. Their in vitro antiproliferative activity was evaluated against eight human tumour cell lines as well as a single normal cell line. All analogues demonstrated powerful to good antiproliferative effects toward all malignant cell lines under evaluation. Against the HL-60 cell line, all mimics showed increased activities being 27- to 1604-fold more potent than the lead compound, (?)-goniofufurone. Remarkably, the majority of synthesized analogues displayed higher or similar activity to the commercial antitumour agent doxorubicin (DOX) against A549 cell line. The most potent compound exhibited 196-fold stronger cytotoxicity than DOX in the culture of this cell line.


Sign in / Sign up

Export Citation Format

Share Document